A population-based incidence of M2 strokes indicates potential expansion of large vessel occlusions amenable to endovascular therapy

作者：Rai Ansaar T; Domico Jennifer R; Buseman Chelsea; Tarabishy Abdul R; Fulks Daniel; Lucke Wold Noelle; Boo SoHyun; Carpenter Jeffrey S

来源：Journal of Neurointerventional Surgery, 2018, 10(6): 510-515.

DOI：10.1136/neurintsurg-2017-013371

• stroke
• thrombectomy
• incidence
• M2

BackgroundM2 occlusions may result in poor outcomes and potentially benefit from endovascular therapy. Data on the rate of M2 strokes is lacking.MethodologyPatients with acute ischemic stroke discharged over a period of 3years from a tertiary level hospital in the stroke belt' were evaluated for M2 occlusions on baseline vascular imaging. Regional and national incidence was calculated from discharge and multicounty data.ResultsThere were 2739 ICD-9 based AIS discharges. M2 occlusions in 116 (4%, 95%CI 3.5% to 5%) patients constituted the second most common occlusion site. The median National Institute of Health Stroke Scale (NIHSS) score was 12 (IQR 5-18). Good outcomes were observed in 43% (95% CI 34% to 53%), poor outcomes in 57% (95% CI 47% to 66%), and death occurred in 27% (95% CI 19% to 37%) of patients. Receiver operating characteristics curves showed the NIHSS to be predictive of outcomes (area under the curve 0.829, 95%CI 0.745 to 0.913, p<0.0001). An NIHSS score 9 was the optimal cut-off point for predicting poor outcomes (sensitivity 85.7%, specificity 67.4%). 71 (61%) patients had an NIHSS score 9and 45 (39%) an NIHSS score <9. The rate of good-outcome was 22.6% for NIHSS score 9 versus 78.4% for NIHSSscore <9 (OR=0.08, 95%CI 0.03 to 0.21, p<0.0001). Mortality was 42% for NIHSS score 9 versus 2.7% for NIHSS score <9 (OR=26, 95%CI 3.3 to 202, p<0.0001). Infarct volume was 57 (55.7) cm(3) for NIHSS score 9versus 30(+/- 34)cm(3) for NIHSS score <9 (p=0.003). IV recombinant tissue plasminogen activator (rtPA) administered in 28 (24%) patients did not affect outcomes. The rate of M2 occlusions was 7 (95% CI 5 to 9)/100 000 people/year (3%, 95%CI 2% to 4%), giving an incidence of 21 176 (95% CI 15 282 to 29 247)/year. Combined with M1, internal carotid artery terminus and basilar artery, this yields a large vessel occlusion (LVO)+M2' rate of 31 (95% CI 26 to 35)/100 000 people/year and a national incidence of 99 227 (95% CI 84 004 to 112005) LVO+M2strokes/year.ConclusionM2 occlusions can present with serious neurological deficits and cause significant morbidity and mortality. Patients with M2 occlusions and higher baseline deficits (NIHSS score 9) may benefit from endovascular therapy, thus potentially expanding the category of acute ischemic strokes amenable to intervention.

• 出版日期2018-6